DocGo Inc. Common Stock earnings per share and revenue
On Nov 10, 2025, DCGO reported earnings of -0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 4.24% surprise. Revenue reached 70.81 million, compared to an expected 71.17 million, with a -0.50% difference. The market reacted with a -0.90% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.13 USD, with revenue projected to reach 71.76 million USD, implying an increase of 18.18% EPS, and increase of 1.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
FAQ
What were DocGo Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, DocGo Inc. Common Stock reported EPS of -$0.11, beating estimates by 4.24%, and revenue of $70.81M, -0.5% below expectations.
How did the market react to DocGo Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.9%, changed from $1.11 before the earnings release to $1.10 the day after.
When is DocGo Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for DocGo Inc. Common Stock's next earnings report?
Based on 9
analysts, DocGo Inc. Common Stock is expected to report EPS of -$0.13 and revenue of $71.76M for Q4 2025.